Company: Siolta Therapeutics
Job title: President, CSO & Co-Founder
Dr. Nikole Kimes is President and Chief Scientific Officer of Siolta Therapeutics, a San Francisco-based biotech company developing novel microbiome-focused strategies for the prevention and treatment of inflammatory diseases. As a founder and the lead executive driving Siolta’s early-stage development, Dr. Kimes heads a talented team of scientists, blending microbiology, immunology, and bioinformatics expertise to leverage microbiome data and research for the improvement of patient stratification and development of precision microbial therapeutics. Dr. Kimes has over a decade of experience in microbial ecology and host/microbe interactions, and her research in Dr. Susan Lynch’s lab at UCSF provided the foundation for the company’s translational research program.
Exploring the Development of Early Life Microbial Interventions to Disrupt the Atopic March 11:00 am
day: Day One